Skip to main content
. 2022 Nov 2;16:1460. doi: 10.3332/ecancer.2022.1460

Table 2. Response rates achieved, resectability at the end of three cycles and toxicity analysis.

Response Three-drug regimen
(n = 31) (%)
Two-drug regimens
(n = 88) (%)
Complete response (CR) 0 0
Partial response (PR) 13 (41.9) 33 (37.5)
Stable disease (SD) 10 (32.3) 35 (39.8)
Progressive disease (PD) 8 (25.8) 20 (22.7)
Resectability achieved 10 (32.3) 23 (26.1)
Resectability not achieved 21 (67.7) 65 (73.9)
Grade 3–4 toxicity
Anaemia 3 (9.7) 23 (26.1)
Febrile neutropenia 6 (19.4) 9 (10.2)
Thrombocytopenia 0 5 (5.7)
Vomiting 1 (3.2) 3 (3.4)
Diarrhoea 3 (9.7) 4 (4.6)
Cardiac event 0 1 (1.1)